TY - GEN
T1 - Innovation on expired patent medicines in the Brazilian pharmaceutical industry
AU - Yugue, R. T.
AU - Maximiano, A. C.A.
AU - Sbragia, R.
AU - Nascimento, P. T.S.
N1 - Publisher Copyright:
© 2018 Portland International Conference on Management of Engineering and Technology, Inc. (PICMET).
PY - 2018/10/4
Y1 - 2018/10/4
N2 - A representative percentage of the medicines manufactured in Brazil is based on expired patent drugs. As the generic drugs market is becoming more competitive and less profitable, incremental innovation is a strategic alternative to survive long term. Our purpose was to identify factors that influence the investment in innovation on patent-expired medicines (PEM) by pharmaceutical laboratories installed in Brazil. We also aimed to propose a theoretical model that would be helpful to understand the innovation process on PEM, main components, influencing factors and their relationships. Data from the market were collected by interviewing experts and executives from the pharmaceutical companies installed in Brazil. The empirical data were analyzed in respect to the proposed theoretical model. We found out that in order to invest in incremental innovations on expired patent drugs it is necessary to develop an appropriate business model to market the new product, which is quite different from the former structure used to generic drugs. We also identified that one of the main difficulties is related to the required professional capabilities for producing the innovations. A case of success is presented as an example of investment in incremental innovation on PEM in Brazil.
AB - A representative percentage of the medicines manufactured in Brazil is based on expired patent drugs. As the generic drugs market is becoming more competitive and less profitable, incremental innovation is a strategic alternative to survive long term. Our purpose was to identify factors that influence the investment in innovation on patent-expired medicines (PEM) by pharmaceutical laboratories installed in Brazil. We also aimed to propose a theoretical model that would be helpful to understand the innovation process on PEM, main components, influencing factors and their relationships. Data from the market were collected by interviewing experts and executives from the pharmaceutical companies installed in Brazil. The empirical data were analyzed in respect to the proposed theoretical model. We found out that in order to invest in incremental innovations on expired patent drugs it is necessary to develop an appropriate business model to market the new product, which is quite different from the former structure used to generic drugs. We also identified that one of the main difficulties is related to the required professional capabilities for producing the innovations. A case of success is presented as an example of investment in incremental innovation on PEM in Brazil.
UR - https://www.scopus.com/pages/publications/85056446454
U2 - 10.23919/PICMET.2018.8481933
DO - 10.23919/PICMET.2018.8481933
M3 - Conference contribution
AN - SCOPUS:85056446454
T3 - PICMET 2018 - Portland International Conference on Management of Engineering and Technology: Managing Technological Entrepreneurship: The Engine for Economic Growth, Proceedings
BT - PICMET 2018 - Portland International Conference on Management of Engineering and Technology
A2 - Steenhuis, Harm-Jan
A2 - Niwa, Kiyoshi
A2 - Perman, Gary
A2 - Kocaoglu, Dundar F.
A2 - Anderson, Timothy R.
A2 - Kozanoglu, Dilek Cetindamar
PB - Institute of Electrical and Electronics Engineers Inc.
T2 - 2018 Portland International Conference on Management of Engineering and Technology, PICMET 2018
Y2 - 19 August 2018 through 23 August 2018
ER -